Eksigent Technologies (Liquid Chromatography Business) is Biotechnology in United States that focus on medical devices business. They cover business area such as manufacturer, liquid chromatography instrument, medical device, each component, NanoLC-Ultra System, proteomic, protein peptide separation, study, pharmacokinetic, drug metabolism, medical sector, drug development.
-
Medical Devices
-
6693 Sierra Lane
Suite A
Dublin, CA 94568
United States
Private
manufacturerliquid chromatography instrumentmedical deviceeach componentNanoLC-Ultra Systemproteomicprotein peptide separationstudypharmacokineticdrug metabolismmedical sectordrug development
* We use standard office opening hours in near Eksigent Technologies (Liquid Chromatography Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Eksigent Technologies (Liquid Chromatography Business) is Biotechnology business from United States that founded in - ( years old in ), Eksigent Technologies (Liquid Chromatography Business) business is focusing on Medical Devices.
Eksigent Technologies (Liquid Chromatography Business) headquarter office and corporate office address is located in 6693 Sierra Lane Suite A Dublin, CA 94568 United States.
Eksigent Technologies (Liquid Chromatography Business) was founded in United States.
In , Eksigent Technologies (Liquid Chromatography Business) is currently focus on medical devices sector.
Above is snippet of Google Trends for "medical devices" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Eksigent Technologies (Liquid Chromatography Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
